Tác động của buspirone đến mức prolactin trong máu và sự chuyển hóa dopamine ở vùng đuôi của chuột cống

Allen LE, Ferguson H, Coc Jr RH (1974) Pharmacologic effects of MJ9022-1, a potential tranquilizing agent. Arzneim Forsch 24:917–922 Alper RH, Demarest KT, Moore KE (1980) Morphine differentially alters synthesis and turnover of dopamine in central neuronal systems. J Neural Transm 48:157–166 Bruni JF, Van Vaugt DA, Meites J (1978) Naloxone inhibition of stress-induced increase in prolaction secretion. Fed Proc 37:556 Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons effect of antipsychotic drugs and amphetamine on single-cell activity. J Pharmacol Exp Ther 185:560–571 Calabro MA, MacLeod RM (1978) Binding of dopamine to bovine anterior pituitary gland membranes. Neuroendocrinology 25:3125:32–46 Carlsson A (1975) Receptor-medicated control of dopamine metabolism. In: Usdin E, Bunney WE (eds) Pre- and postsynaptic receptors. Marcel Dekker, New York, pp 49–63 Carlsson A, Lindqvist M (1963) Effect of CPZ and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20:140–144 Caron MG, Beaulieu M, Raymond V, Gagne B, Drounin R, Lefkowitz J, Labrie F (1978) Dopaminergic receptors in the anterior pituitary gland. J Biol Chem 253:2244–2253 Cronin MJ, Roberts JM, Weiner RI (1978) Dopamine and dihydroergocryptine binding to the anterior pituitary and other brain areas of the rat and sheep. Endocrinology 103:302–309 Demarest KT, Moore KE (1979) Comparison of dopamine synthesis regulation in the terminals of nigro-striatal, mesolimbic, tuberoin-fundibular and tuberohypophyseal neurons. J Neural Transm 46:263–277 Denef C, Follebouckt JJ (1978) Differential effects of dopamine antagonists on prolactin secretion from cultured rat pituitary cells. Life Sci 23:431–436 DiChiara G, Porceddu ML, Vargiu L, Stefanini E, Gessa GL (1977) Evidence for selective and long-lasting stimulation of “regulatory” dopamine receptors by bromocriptine (CB 154). Naunyn-Schmiedeberg's Arch Pharmacol 300:239–246 Goldberg HL, Finnerty RJ (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 136:1184–1187 Gudelsky GA, Porter JC (1979) Release of newly synthesized dopamine into the hypophysial portal vasculature of the rat. Endocrinology 106:526–529 Hjorth S, Carlsson A, Wikstrom H, Lindberg P, Sanchez D, Hacksell U, Arvidsson LE, Svensson U, Nilsson JLG (1981) 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sci 28:1225–1238 MacLeod RM (1976) Regulation of PRL secretion. In: Martin L, Ganong WF (eds) Frontiers in neuroendocrinology, vol 4. Raven, New York, pp 169–194 McMillen BA, Sanghera, MK, Matthews RT, German DC (1981) The effect of buspirone, a novel anxiolytic drug, on rat brain dopaminergic neurotransmission. Soc Neurosci Abstr 7:575 Meltzer HY, Daniels S, Fang VS (1975) Clozapine increases rat serum prolactin levels. Life Sci 17:339–342 Meltzer HY, Goode DJ, Fang VS (1978a) The effect of psychotropic drugs on endocrine function. I. Neuroleptics, precursors and agonists. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven, New York, pp 509–529 Meltzer HY, Fang VS (1976) Effect of apomorphine plus 5-hydroxytroptophan on plasma prolactin levels in male rats. Psychopharmacol Commun 2:189–198 Meltzer HY, Fessler RG, Simonovic M, Fang VS (1978b) Stimulation of rat prolactin secretion by indoleakylamine hallucinogens. Psychopharmacology 56:255–260 Meltzer HY, Simonovic M (1981) Effect of 3-PPP, a putative dopamine autoreceptor agonist, on rat serum prolactin levels. Life Sci 29:99–105 Meltzer HY, Simonovic M, Fang VS, Piyakalamala S, Young M (1978c) A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors. Life Sci 23:605–610 Reimann W, Zumstein A, Sackrisch R, Starke K, Hertting G (1979) Effect of extracellular dopamine on the release of dopamine in the rabbit caudate nucleus: Evidence for a dopaminergic feedback inhibition. Naunyn-Schmiedeberg's Arch Pharmacol 306:53 Riblet LA, Taylor DP, Becker JA, Hyslop DK, Wilderman RC (1981) Buspirone: An anxioselective drug with similarities to apomorphine. Soc Neurosci Abstr 7:865 Sasa S, Blank CL (1977) Determination of serotonin and dopamine in mouse brain tissue by high-performance liquid chromatography with electrochemical detection. Anal Chem 49:354–359 Sathananthan GL, Sanghavi I, Phillips N, Gershon S (1975) MJ9022: Correlation between neuroleptic potential and stereotypy. Curr Ther Res 18:701–705 Stanton HC, Taylor DP, Riblet LA (1981) Buspirone: An anxioselective drug with dopaminergic action. In: Chronister RB, DeFrance JF (eds) The neurobiology of the nucleus accumbens. Haer Institute, Brunswick Maine, pp 316–321 Taylor DP, Hyslop DK, Riblet LA (1980) Buspirone: A model for anxioselective drug action. Soc Neurosci Abstr 6:791 Tompkins EC, Clemento AJ, Taylor DP, Perhach Jr JL (1980) Inhibition of aggressive behavior in rhesus monkeys by buspirone. Res Commun Psychol Psychiat Behav 5:337–352 Weeks JR, Davis JD (1964) Chronic intravenous cannulas for rats. J Appl Physiol 19:540–541 Wu YH, Rayburn JW, Allen LE, Ferguson HC, Kissel JW (1972) Psychosedative agents. 2. 8-(4-substituted 1-piperazinylalkyl)-8-azaspiro-4,5-decane-7,9-diones. J Med Chem 14:477–479